The University of Chicago Header Logo

Connection

Girish Venkataraman to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Imatinib Mesylate.
Girish Venkataraman
Connection Strength
0.025
Imatinib Mesylate
  1. Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML). Pathology. 2012 Jan; 44(1):59.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.